Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Registry on Patients With Advanced NSCLC Harboring METex14 Skipping Alterations (MOMENT)

NCT05376891 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.

NCT NCT05376891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05376891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Registry on Patients With Advanced NSCLC Harboring METex14 Skipping Alterations (MOMENT)
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Phase
Observational
Overall status
Recruiting
Start date
October 4, 2022
Completion date
April 28, 2028
Enrollment
700 (estimated)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

cancer